首页> 外文OA文献 >Somatostatin Receptor Avidity in Gastrointestinal Stromal Tumors: Theranostic Implications of Gallium-68 Scan and Eligibility for Peptide Receptor Radionuclide Therapy

【2h】

Somatostatin Receptor Avidity in Gastrointestinal Stromal Tumors: Theranostic Implications of Gallium-68 Scan and Eligibility for Peptide Receptor Radionuclide Therapy

机译：生长抑素受体在胃肠道间质瘤中的耐酸体：镓-68扫描和肽受体放射性核素疗法的扫描和资格的治疗方法

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Arturo Loaiza-Bonilla; Paula A Bonilla-Reyes;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Somatostatin Receptor Avidity in Gastrointestinal Stromal Tumors: Theranostic Implications of Gallium-68 Scan and Eligibility for Peptide Receptor Radionuclide Therapy [J] . Arturo Loaiza-Bonilla, Paula A. Bonilla-Reyes Cureus. . 2017,第9期

机译：胃肠道间质瘤中的生长抑素受体亲和力：镓68扫描和肽受体放射性核素治疗资格的血清学意义。
2. Somatostatin receptor imaging in non-131I-avid metastatic differentiated thyroid carcinoma for determining the feasibility of peptide receptor radionuclide therapy with 177Lu-DOTATATE: Low fraction of patients suitable for peptide receptor radionuclide therapy and evidence of chromogranin a level-positive neuroendocrine differentiation [J] . JoisB., AsopaR., BasuS. Clinical nuclear medicine . 2014,第6期

机译：非131I-avid转移性甲状腺癌的生长抑素受体显像以确定177Lu-DOTATATE进行肽受体放射性核素治疗的可行性：低比例的患者适合进行肽受体放射性核素治疗和嗜铬粒蛋白水平阳性的神经内分泌分化的证据
3. Theranostics with Ga-68 somatostatin receptor PET/CT: Monitoring response to peptide receptor radionuclide therapy [J] . KulkarniH.R., BaumR.P. PET clinics . 2014,第1期

机译：Ga-68生长抑素受体PET / CT的治疗学：监测对肽受体放射性核素治疗的反应
4. Radiolabelling of DOTA-TATE with ~177Lu. Preliminary Studies with a View to Somatostatin Receptor Radionuclide Therapy [C] . V. Lungu, D. Niculae, L. Danaila, International Conference on Isotopes (5ICI) . 2005

机译：用〜177室的Dota-tate放射性标记。初步研究以索抑素受体放射性核素治疗的视图
5. Gallium-68 and fluorine-18 labeling of a peptide binding to the human transferrin receptor and determination of its uptake into transferrin receptor-expressing human cell lines [D] . Nada, Dina 2010

机译：与人运铁蛋白受体结合的肽的镓68和氟18标记及其在表达运铁蛋白受体的人细胞系中的摄取测定
6. Somatostatin Receptor Avidity in Gastrointestinal Stromal Tumors: Theranostic Implications of Gallium-68 Scan and Eligibility for Peptide Receptor Radionuclide Therapy [O] . Arturo Loaiza-Bonilla, Paula A Bonilla-Reyes -1

机译：胃肠道间质瘤中的生长抑素受体亲和力：镓68扫描和肽受体放射性核素治疗资格的血清学意义。
7. Effect of Peptide Receptor Radionuclide Therapy on Somatostatin Receptor Status and Glucose Metabolism in Neuroendocrine Tumors: Intraindividual Comparison of Ga-68 DOTANOC PET/CT and F-18 FDG PET/CT [O] . Oh, Sowon, Prasad, Vikas, Lee, Dong Soo, 2011

机译：肽受体放射性核素治疗对神经内分泌肿瘤中生长抑素受体状态和葡萄糖代谢的影响：Ga-68 DOTANOC PET / CT和F-18 FDG PET / CT的个体比较
8. Induction of Human Somatostatin Receptor Subtype 2 on Breast Tumors with an Adenoviral Vector for Their Treatment and Detection with a Radiolabeled Peptide [R] . Rogers, B. E. 2002

机译：用腺病毒载体诱导人生长抑素受体亚型2在乳腺肿瘤中用放射性标记肽进行治疗和检测

Somatostatin Receptor Avidity in Gastrointestinal Stromal Tumors: Theranostic Implications of Gallium-68 Scan and Eligibility for Peptide Receptor Radionuclide Therapy

著录项

引文网络

相似文献

相关主题

期刊订阅